细胞免疫疗法在小儿呼吸道合胞病毒肺炎临床疗效研究

Clinical Study of Cellular Immunotherapy in Children with Respiratory Syncytial Virus Pneumonia

目的:分析细胞免疫疗法在小儿呼吸道合胞病毒肺炎临床疗效研究。方法:将某院收取的120例小儿呼吸道合胞病毒肺炎作为分析对象,按照住院顺序分成两组各60例,对照组小儿采用临床常规治疗,而观察组小儿在对照组治疗的基础之上增加细胞免疫疗法,对比两组临床治疗的效果和治疗后并发症情况。结果:观察组小儿临床治疗的效果明显优于对照组(P<0.05);观察组小儿治疗后并发症情况明显优于对照组(P<0.05)。结论:针对小儿呼吸道合胞病毒肺炎采取临床细胞免疫疗法效果较好,安全性质较高,值得临床大力推广。

Objective：To analyze the clinical efficacy of cellular immunotherapy in children with respiratory syncytial virus pneumonia.Methods： 120 cases of children with respiratory syncytial virus pneumonia were collected as the subjects. According to the hospitalization order, 60 cases were divided into two groups. The children in the control group were treated with routine therapy. The children in the observation group were treated with Cell immunotherapy on the basis of the control group.Then compare the effect of clinical treatment and post - treatment complications of the two groups. Results： The clinical effect of the observation group was significantly better than that of the control group （P〈0.05）.The complication rate of the observa t ion group was significantly better than that of the control group （P〈0.05）.Conclusion：The clinical effect of clinical cell immunotherapy for children with respiratory syncytial virus pneumonia is better and the safety is high, which is worthy of popularization.